These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6111334)

  • 41. Platelet aggregation and intracellular calcium mobilisation responses are enhanced by cyclosporin A but not by pimecrolimus (SDZ ASM 981).
    Fox SC; Judge HM; Allen BR; Heptinstall S
    Platelets; 2002 Jun; 13(4):213-8. PubMed ID: 12189022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of ethanol and serotonin on rat platelet aggregation.
    Chabielska E; Malinowska B; Buczko W
    Pharmacology; 1990; 40(5):288-92. PubMed ID: 2274574
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The relationship between plasma and red blood cell neuroleptic levels, oral dosage, and clinical parameters in a chronic schizophrenic population.
    Dunlop SR; Shea PA; Hendrie HC
    Biol Psychiatry; 1982 Aug; 17(8):929-36. PubMed ID: 6126231
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 5-hydroxytryptamine and platelet aggregation.
    De Clerck FF; Herman AG
    Fed Proc; 1983 Feb; 42(2):228-32. PubMed ID: 6822293
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of 5-hydroxytryptamine-potentiated aggregation of human blood platelets by 5-hydroxytryptamine receptor-blocking agents.
    Glusa E; Markwardt F
    Biomed Biochim Acta; 1984; 43(2):215-20. PubMed ID: 6732757
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ability of whole blood aggregometer to detect platelet hyperaggregability.
    Abbate R; Boddi M; Prisco D; Gensini GF
    Am J Clin Pathol; 1989 Feb; 91(2):159-64. PubMed ID: 2916459
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP; Maguire MH
    Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blood biogenic amines during clozapine treatment of early-onset schizophrenia.
    Schulz E; Fleischhaker C; Clement HW; Remschmidt H
    J Neural Transm (Vienna); 1997; 104(10):1077-89. PubMed ID: 9503259
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Platelet function in C6-deficient rabbits. Aggregation and secretion induced by collagen and zymosan.
    Christian FA; Gordon JL
    Immunology; 1975 Jul; 29(1):131-41. PubMed ID: 1140824
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The actions of flupenthixol upon 5-hydroxytryptamine-induced aggregation and the uptake of 5-hydroxytryptamine and dopamine by human blood platelets.
    Boullin DJ; Grimes RP; Orr MW
    Br J Pharmacol; 1975 Dec; 55(4):555-7. PubMed ID: 2360
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of haloperidol and chlorpromazine on smooth muscle contractility, platelet aggregation and neuronal calcium current.
    Prokopenko RA; Mogilevich SE; Luik AI; Naydyenova IY; Batrak GN; Hawryluk BR; Degtiar VY
    Gen Physiol Biophys; 1995 Aug; 14(4):349-57. PubMed ID: 8720698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Perspectives on a time-dependent model of neuroleptic action.
    Pickar D
    Schizophr Bull; 1988; 14(2):255-68. PubMed ID: 2904694
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition and reversal of platelet aggregation by alphaIIbbeta3 antagonists depends on the anticoagulant and flow conditions: differential effects of Abciximab and Lamifiban.
    Frojmovic M; Labarthe B; Legrand C
    Br J Haematol; 2005 Nov; 131(3):348-55. PubMed ID: 16225655
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alternate complement pathway induction of aggregation and release of 5-hydroxytryptamine and adenosine diphosphate by rabbit platelets.
    Marney SR; Colley DG; Des Prez RM
    J Immunol; 1975 Feb; 114(2 Pt 1):696-703. PubMed ID: 804512
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of immunosuppressive drugs on platelet aggregation in vitro.
    Małyszko J; Małyszko JS; Takada A; Myśliwiec M
    Ann Transplant; 2002; 7(1):55-68. PubMed ID: 12221905
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of nicotine on platelet function.
    Pfueller SL; Burns P; Mak K; Firkin BG
    Haemostasis; 1988; 18(3):163-9. PubMed ID: 3181816
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduced susceptibility to oxidative damage of erythrocyte membranes from medicated schizophrenic patients.
    Ramchand CN; Davies JI; Tresman RL; Griffiths IC; Peet M
    Prostaglandins Leukot Essent Fatty Acids; 1996 Aug; 55(1-2):27-31. PubMed ID: 8888120
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Psychotropic drugs and gender as modifiers of the role of plasma tryptophan and serotonin in schizophrenia.
    Lovett Doust JW; Huszka L; Lovett Doust JN
    Compr Psychiatry; 1975; 16(4):349-55. PubMed ID: 239833
    [No Abstract]   [Full Text] [Related]  

  • 59. Assessment of anti-psychotic drugs.
    Mackay AV
    Br J Clin Pharmacol; 1981 Mar; 11(3):225-36. PubMed ID: 6111332
    [No Abstract]   [Full Text] [Related]  

  • 60. Human platelet 5-hydroxytryptamine receptors: binding of [3H]-lysergic acid diethylamide (LSD). Effects of chronic neuroleptic and antidepressant drug administration.
    Grahame-Smith DG; Geaney DP; Schachter M; Elliott JM
    Experientia; 1988 Feb; 44(2):142-5. PubMed ID: 2894321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.